Factors of Transference

Salt Lake City, Utah (May 11, 2009)
4Life Research ™ announced today the conclusion of a new preliminary scientific test, which one shows the effect of 4Life Transfer Factor Tri-Factor ® Formulates in the production of the antibody IgA. The participants took 4Life Transfer Factor Tri-Factor Formula for two weeks continued for two additional weeks consuming 4Life Transfer Factor RioVida ® Tri-Factor Formula. Hundred per cent of the participants saw IgA an increase in the cup of production of the secretion salivating when it was compared with one week like base, with an average of increase of 73 %. Click here to see the illustration.Un cien por ciento de los participantes vieron un incremento en la taza de producción de la secreción salivar IgA cuando se comparó con una semana como base, con un promedio de incremento del 73%. Haz click aquí para ver la ilustración.

The antibodies IgA, produced by plasmatic cells, are highly specific proteins used by the immune system to catch and to neutralize external invaders. The antibodies IgA cover the surface of the mucous membranes. These proteins in the shape of "y" catch the invaders, preparing that adhere to the mucous walls and enter the textiles and the blood stream of the body. Estas proteínas en forma de “y” atrapan a los invasores, previniendo que se adhieran a las paredes mucosas y entren a los tejidos y el torrente sanguíneo del cuerpo.

The test was realized by Director-general Ejecutivo of 4Life David Lisonbee; Director-general Científico Calvin McCausland, Ph. D.; the member of the Council of Medical sciences Richard Bennett, Ph. D.; the Service manager of Information of the Health Brent Vaughan; and the Scientific Investigator Shane Lefler.D.; el miembro del Consejo de Ciencias Médicas Richard Bennett, Ph.D.; el Director de Servicios de Información de la Salud Brent Vaughan; y el Investigador Científico Shane Lefler.

“I feel proud to be associated with a company that values greatly the scientific investigation”, mentioned McCausland. “It is wonderful to provide products of effective support for the immune system that in turn are sustained by sure scientific studies”.

“The skill of 4Life Transfer Factor does not stop impressing me to stimulate and to endorse the immune system”, said Bennett. “This preliminary IgA study raises the existence of a vital layer of protection of the immune system that 4Life Transfer Factor provides”. “The team of Research and development of 4Life Research has defined that 4Life Transfer Factor can give support to another vital component of a healthy immune system the antibodies IgA — Proving once again our commitment to be supported to the avant-garde of the science of the immune system”, he noticed Lisonbee. “El equipo de Investigación y Desarrollo de 4Life Research ha definido que 4Life Transfer Factor puede dar respaldo a otro componente vital de un sistema inmunológico saludable—los anticuerpos IgA—probando una vez más nuestro compromiso de mantenernos a la vanguardia de la ciencia del sistema inmunológico”, remarcó Lisonbee.

4Life Research, the creator of the category of the Science Transferceutical ™ and world leader in the distribution of the products of support Transfer Factor, keeps on demonstrating growth in more than 40 countries about the world.